Asan Medical Center
Seoul, 05505, South Korea
NCT Number: NCT03027219
We aim to evaluate the flow change of arterial anastomosis site during free flap surgery in diabetic patients.
Looking for future studies?
Notify Me18 year–79 year
All sexes
Observational
Seoul, 05505, South Korea
Objective: flow change of arterial anastomosis site during free flap surgery in diabetic patients.
Background: No research was published about flow change of arterial anastomosis site of the free flap during surgery.
Plan: Using Duplex sonography, various parameters related flap perfusion will be evaluated before and after the administration of alprostadil.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Vasodilator for anastomosis-site of free flap
Other names: Eglandin
Time frame: before alprostadil administration, 30 mins after alprostadil administration
Peak velocity of anastomosis-site of free flap
Asan Medical Center
Other
Prospective Observational Study of the Changes of Blood Flow of Arterial Anastomosis-site of Free Flap in Diabetic Patients Who Undergoing Free Flap Transfer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00837122
Cardiovascular Diseases, Diabetes
Accra, Ghana
View Trial DetailsNCT03899883
Diabetes, Diabetes Complications
Aurora, Colorado, United States
View Trial DetailsNCT00065676
Body Weight, Diabetes
Bethesda, Maryland, United States
View Trial DetailsNCT00862433
Body Weight, Diabetes
Bethesda, Maryland, United States
View Trial Details